An EMA committee has recommended approval of Alvotech’s AVT06, a biosimilar to Bayer’s blockbuster ophthalmology drug Eylea.

Under the renewed deal, Bayer and Tsinghua University will work to enhance the drug discovery and development process across ...

Pharma giant Bayer is launching a precision health unit as it ramps up its investment in consumer-facing digital health tools. The company will prioritize developing products that enable people to ...

However, Bayer's top-selling pharma product Xarelto (rivaroxaban), an anticoagulant, continued to succumb to generic competition with a near-11% fall to €904 million.

If President Trump's threat to impose tariffs on pharmaceutical products goes through, it would have severe consequences for industry R&D efforts, according to a Bayer (OTCPK:BAYZF) pharma executive.

Germany’s Formycon announced that Klinge Biopharma, the exclusive owner of the global commercialization rights of ...

WHIPPANY, N.J., January 14, 2025--On the occasion of the 43rd J.P. Morgan Healthcare Conference in San Francisco, Bayer AG announces further progress in its pharmaceutical growth strategy with ...

Germany's Bayer will contract a third party to distribute its pharmaceutical products in four African markets including Kenya, it said, adding that the impact on jobs will be minimal.

Leverkusen, the city, was built to serve the company. Today, the football team remains a wholly-owned subsidiary of Bayer, with a presence in more than 80 countries and revenues in 2023 of € ...